Search Within

Weinberg Fellows

Formats
  1. Meeting Abstract (1375)
  2. Journal Article (1150)
  3. Review (130)
  4. Editorial (65)
  5. Research Letter (36)
  6. Book Section (25)
  7. Correspondence (24)
  8. Guidelines (12)
  9. Conference Paper (2)
  10. Miscellaneous (1)
Groups
  1. Hematology-Oncology Fellows (2747)
  2. Department of Medicine (2704)
  3. Solid Tumor Oncology Division (2003)
  4. Hematologic Malignancies, Division of (1330)
  5. GSK Faculty (1228)
  6. Department of Pathology and Laboratory Medicine (982)

More Groups

People
  1. Michael Berger (218)
  2. Marc Ladanyi (198)
  3. Pedram Razavi (184)
  4. Michael Offin (176)
  5. Sergio Giralt (171)
  6. Maria Carlo (168)

More People

Years
  1. 2025 (207)
  2. 2024 (414)
  3. 2023 (330)
  4. 2022 (377)
  5. 2021 (339)
  6. 2020 (323)

More Years

Publications
  1. Journal of Clinical Oncology (568)
  2. Blood (299)
  3. Annals of Oncology (107)
  4. Clinical Cancer Research (102)
  5. Journal of Thoracic Oncology (96)
  6. Cancer Research (87)

More Publications

Publishers
  1. American Society of Clinical Oncology (643)
  2. Elsevier Inc. (343)
  3. American Society of Hematology (339)
  4. American Association for Cancer Research (239)
  5. Nature Publishing Group (201)
  6. Oxford University Press (157)

More Publishers

Results (2820)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • STK11/LKB1 genomic alterations are associated with inferior clinical outcomes with chemo-immunotherapy in non-squamous NSCLC
    Meeting Abstract

    Skoulidis, F.; Arbour, K.; Hellmann, M.; Patil, P.; Marmarelis, M.; Owen, D.; Awad, M.; Murray, J.; Levy, B.; Hellyer, J.; more...
    Journal of Thoracic Oncology (2019)

    Fulltext@MSK | Save
  • Early change of dNLR is correlated with outcomes in advanced NSCLC patients treated with immunotherapy
    Meeting Abstract

    Mezquita, L.; Preeshagul, I.; Auclin, E.; Saravia, D.; Hendriks, L.; Rizvi, H.; Planchard, D.; Park, W.; Nadal, E.; Ruffinelli, J. C.; more...
    Journal of Thoracic Oncology (2019)

    Fulltext@MSK | Save
  • Multifactorial model to predict response to PD-(L)1 blockade in patients with high PD-L1 metastatic non-small cell lung cancer
    Meeting Abstract

    Arbour, K.; Oprescu, M.; Hakim, J.; Rizvi, H.; Leiserson, M.; Ginsburg, M.; Plodkowski, A.; Sauter, J.; Preeshagul, I.; Gillett, S.; more...
    Journal of Thoracic Oncology (2019)

    Fulltext@MSK | Save
  • Integrated germline and somatic analysis identifies actionable cancer predisposing germline mutations in 9,734 patients with advanced cancers
    Meeting Abstract

    Jayakumaran, G.; Mandelker, D.; Birsoy, O.; Jairam, S.; Li, Y.; Yang, C.; Somar, J.; Rai, V.; Syed, A.; Benayed, R.; more...
    Journal of Molecular Diagnostics (2019)

    Fulltext@MSK | Save
  • Phase 1 study of the CD40 agonist monoclonal antibody (mAb) CDX-1140 alone and in combination with CDX-301 (rhFLT3L) in patients with advanced cancers
    Meeting Abstract

    Sanborn, R.; Gabrail, N.; O'Hara, M.; Bhardwaj, N.; Gordon, M.; Hauke, R.; Bordoni, R.; Khalil, D.; Rawls, T.; Vitale, L.; more...
    Journal for ImmunoTherapy of Cancer (2019)

    Fulltext@MSK | Save
  • A phase 2 efficacy and safety trial of ADU-S100 and pembrolizumab in adults with head and neck cancer
    Meeting Abstract

    Cohen, E.; Ferris, R.; Adkins, D.; Zandberg, D.; Dudek, A.; Mathew, M.; Dunn, L.; Grilley-Olson, J.; Sukari, A.; Redman, R.; more...
    Journal for ImmunoTherapy of Cancer (2019)

    Fulltext@MSK | Save
  • Phase II study of 2 dosing regimens of cemiplimab, a human monoclonal anti-PD-1, in metastatic cutaneous squamous cell carcinoma (mCSCC)
    Meeting Abstract

    Rischin, D.; Lim, A. M.; Schmults, C. D.; Khushalani, N. I.; Hughes, B. G.; Schadendorf, D.; Dunn, L. A.; Chang, A. L. S.; Hauschild, A.; Ulrich, C.; more...
    Annals of Oncology (2019)

    Fulltext@MSK | Save
  • First-line pembrolizumab (P), trastuzumab (T), capecitabine (C) and oxaliplatin (O) in HER2-positive metastatic esophagogastric adenocarcinoma
    Meeting Abstract

    Janjigian, Y. Y.; Maron, S.; Chou, J. F.; Gabler, A. R.; Simmons, M. Z.; Momtaz, P.; Shcherba, M.; Ku, G. Y.; Won, E.; Sanchez-Vega, F.; more...
    Annals of Oncology (2019)

    Fulltext@MSK | Save
  • Towards individualized therapy for metastatic renal cell carcinoma
    Review

    Kotecha, R. R.; Motzer, R. J.; Voss, M. H.
    Nature Reviews Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Familial kidney cancer: Implications of new syndromes and molecular insights
    Review

    Carlo, M. I.; Hakimi, A. A.; Stewart, G. D.; Bratslavsky, G.; Brugarolas, J.; Chen, Y. B.; Linehan, W. M.; Maher, E. R.; Merino, M. J.; Offit, K.; more...
    European Urology (2019)

    Fulltext@MSK | Save